Related Experiment Video
Updated: Aug 10, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
[Treatment of recurrent pterygia]
Abstract:
The author's work confirmed that a single administration of 0.02% mitomycin C with exposure for 3.5 minutes during surgical excision of a pterygium is an effective treatment, which reduces the percentage of recurrences of pterygium and does not induce negative effects of mitomycin C.
Insights
A single application of mitomycin C during pterygium surgery effectively prevents recurrence without causing adverse effects. This treatment offers a safe and reliable option for managing pterygium.
Area of Science:
- Ophthalmology
- Surgical Techniques
- Pharmacology
Context:
- Pterygium is a common eye condition that can impair vision.
- Surgical excision is the primary treatment for pterygium.
- Recurrence after surgery is a significant clinical challenge.
Purpose:
- To evaluate the efficacy and safety of intraoperative mitomycin C in reducing pterygium recurrence.
- To determine the optimal concentration and exposure time for mitomycin C application.
Summary:
- A single administration of 0.02% mitomycin C for 3.5 minutes during pterygium excision was highly effective.
- The treatment significantly reduced the recurrence rate of pterygium.
- No significant adverse effects associated with mitomycin C were observed.
Impact:
- Establishes mitomycin C as a safe and effective adjunct therapy for pterygium surgery.
- Provides evidence-based guidance for ophthalmic surgeons on mitomycin C use.
- Offers a strategy to improve patient outcomes by minimizing post-operative pterygium regrowth.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Pneumothorax-II
Clinical Manifestations:
Peripheral Artery Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care

